SST and type 2 diabetes mellitus: The mean somatostatin concentration in T2D subjects (0.37 ± 0.25 μg/g) was not significantly different from that in ND subjects (0.46 ± 0.24 μg/g) or in the two subgroups of controls (Fig. 1C).